[Adverse effects of multi-drug therapy in patients with tuberculosis and ways of their correction].
Thirty and seventy six patients with tuberculosis receiving multidrug therapy and 107 healthy persons were examined. There is a high rate (38.5%) of adverse responses to antibiotics, deteriorated baseline vitamin deficiency, PLO-AOA imbalance, poorer liver tests, preserved protein deficiency, and secondary immunodeficiency. The use of Trofosan, an enterosorbent-antioxidant complex, and MRT as pathogenetic drugs corrects the disorders found. With this, the incidence of adverse decreased on the average by 2 times and the efficiency of inpatient treatment increased.